EarlySense, an Israeli company which develops contact free monitoring solutions, announced that it has been approved to distribute its latest Bedside Monitor and Central Display System in the Canadian Market. The company has boasted that it is bringing to Canada a unique solution that empowers clinicians to provide efficient, safe care based on early indication of high risk situations for falls, pressure ulcers or deterioration such as caused by Opioid therapy.
According to EarlySense, after monitoring over quarter of a million patients, results have shown significant clinical improvements in reducing patient falls, pressure ulcers and capturing a patient’s deterioration sooner. The results have demonstrated significant reductions in the average stay in the ICU for patients transferred from a general medical surgical environment, fewer code blue events and shorter overall length of stay, thereby improving care and reducing cost.
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at [email protected].
Thank you.
The company’s solutions monitor patients’ heart and respiratory rate, as well as movement, with a unique sensor that is placed under the mattress. The system was designed to address safety challenges as well as failure to rescue of those patients who are usually monitored by nursing staff approximately once every four to eight hours in general care floors and alternate care facilities
“We are pleased that yet another major regulatory agency has cleared the EarlySense Technology for use in a very important healthcare market.” said Dalia Argaman, VP of Clinical and Regulatory Affairs & QA of EarlySense. “We are excited to begin our work in the Canadian healthcare communities to hopefully bring similar benefits to patients and caregivers as have been realized in other significant healthcare markets.”
“We are looking forward to working closely with Canada’s medical community.” said Tim O’Malley, President of EarlySense Inc. “We believe that EarlySense can provide added safety and assist in facilitating timely interventions for patients in non-ICU settings and alternate care facilities throughout Canada. We are currently developing partnerships with Canadian companies who will bring the EarlySense technology to market in Canada.”
EarlySense’s North American headquarters are in Waltham, MA, and the International headquarters are based in Israel. The EarlySense System is currently installed in hospitals and alternate care facilities in the USA, Europe, Asia and Australia. For more information, visit EarlySense.com.
